Thrivent Financial For Lutherans Nevro Corp Transaction History

Thrivent Financial For Lutherans

$52.6 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$59.95 - $92.06 $16.9 Million - $25.9 Million	-281,256 Closed	0 $0
Q4 2021 Feb 16, 2022	SELL	$81.07 - $121.29 $494,770 - $740,232	-6,103 Reduced 2.12%	281,256 $22.8 Million
Q3 2021 Nov 15, 2021	BUY	$101.99 - $166.36 $1.87 Million - $3.05 Million	18,304 Added 6.8%	287,359 $33.4 Million
Q2 2021 Aug 19, 2021	BUY	$141.6 - $179.06 $1.59 Million - $2.01 Million	11,199 Added 4.34%	269,055 $44.6 Million
Q1 2021 May 17, 2021	BUY	$132.81 - $182.18 $3.84 Million - $5.27 Million	28,935 Added 12.64%	257,856 $36 Million
Q4 2020 Feb 16, 2021	SELL	$138.17 - $184.34 $3.43 Million - $4.57 Million	-24,802 Reduced 9.78%	228,921 $39.6 Million
Q3 2020 Nov 10, 2020	SELL	$114.09 - $145.51 $780,147 - $994,997	-6,838 Reduced 2.62%	253,723 $35.3 Million
Q2 2020 Aug 12, 2020	BUY	$89.45 - $129.85 $15.8 Million - $22.9 Million	176,111 Added 208.54%	260,561 $31.1 Million
Q1 2020 May 15, 2020	BUY	$70.23 - $144.31 $2.29 Million - $4.71 Million	32,635 Added 62.98%	84,450 $8.44 Million
Q4 2019 Feb 13, 2020	BUY	$76.41 - $117.54 $417,962 - $642,943	5,470 Added 11.8%	51,815 $6.09 Million
Q3 2019 Nov 14, 2019	BUY	$61.52 - $91.1 $82,805 - $122,620	1,346 Added 2.99%	46,345 $3.99 Million
Q2 2019 Aug 13, 2019	BUY	$58.04 - $66.99 $33,024 - $38,117	569 Added 1.28%	44,999 $2.92 Million
Q1 2019 May 14, 2019	SELL	$35.52 - $62.62 $1.41 Million - $2.48 Million	-39,676 Reduced 47.17%	44,430 $2.78 Million
Q4 2018 Feb 15, 2019	SELL	$35.43 - $56.29 $2.77 Million - $4.4 Million	-78,218 Reduced 48.19%	84,106 $3.27 Million
Q3 2018 Nov 15, 2018	SELL	$44.22 - $75.47 $864,103 - $1.47 Million	-19,541 Reduced 10.74%	162,324 $9.25 Million
Q2 2018 Aug 14, 2018	SELL	$72.38 - $92.5 $2.19 Million - $2.8 Million	-30,265 Reduced 14.27%	181,865 $14.5 Million
Q1 2018 May 08, 2018	BUY	$69.46 - $88.57 $129,890 - $165,625	1,870 Added 0.89%	212,130 $18.4 Million
Q3 2017 Nov 14, 2017	BUY	$80.87 - $91.08 $17 Million - $19.2 Million	210,260	210,260 $19.1 Million

Others Institutions Holding NVRO

# of Institutions

151

Shares Held

39.3M

Call Options Held

67.9K

Put Options Held

1.59M

Arrow Mark Colorado Holdings LLC Denver, CO

4.39M
Shares

$18.2 Million
0.35% of portfolio
Armistice Capital, LLC New York, NY

3.73M
Shares

$15.5 Million
0.35% of portfolio
Black Rock Inc. New York, NY

3.6M
Shares

$14.9 Million
0.0% of portfolio
Glenn Welling Engaged Capital LLC | Newport Beach, Ca

2.44M
Shares

$10.1 Million
2.49% of portfolio
Vanguard Group Inc Valley Forge, PA

2.1M
Shares

$8.7 Million
0.0% of portfolio

View Full List

About NEVRO CORP

Ticker NVRO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,387,800
Market Cap $147M
Description
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...

More about NVRO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Thrivent Financial For Lutherans, based on Form 13F filings with the SEC.

News

Stay updated on Thrivent Financial For Lutherans with notifications on news.

Account